We are live on ! Find out more
NBTX

Nanobiotix
NBTX

5 hedge funds and large institutions have $12.2M invested in Nanobiotix in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% more ownership

Funds ownership: 9.93% → 9.94% (+0.01%)

0% more funds holding

Funds holding: 5 → 5 (0)

0% less capital invested

Capital invested by funds: $12.2M → $12.2M (-$23.6K)

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$2.91K

Top Sellers

No sellers this quarter

NBTX Hedge Fund Activity: Q4 2022 in Review

5 of the 6,239 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q4 2022, worth a combined $12.2M — down 0.19% from $12.2M a quarter earlier.

Fund positioning in NBTX was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $2.91K.

  • 5 institutional investors held Nanobiotix (NBTX) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $12.2M of Nanobiotix stock for Q4 2022, down 0.19% quarter-over-quarter.
  • 0 funds opened new Nanobiotix positions in Q4 2022 and 0 closed out.
  • The largest Nanobiotix buyer in Q4 2022 was UBS Group, an estimated $2.91K added.

Based on aggregated 13F filings for Q4 2022.